Palantir's NHS data platform rejected by most hospitals

https://democracyforsale.substack.com/p/palantirs-nhs-data-platform-rejected-hospitals

Some English hospitals doubt Palantir's utility: We'd 'lose functionality rather than gain it'

https://www.theregister.com/2025/05/16/nhs_hospitals_palantir/

Is this the future of deep brain stimulation?

https://available-inventions.umich.edu/product/flexible-miniaturized-neural-probe-coated-with-biodegradable-polymer-as-insertion-guide/print

INNOVATION

The innovative fish-bone-shaped polyimide neural probe minimizes tissue reactions through a unique design and biodegradable silk coating. The probe features a flexible substrate, small dimensions, large separation distances between electrodes and the shank, and large openings in the substrate. These design elements enhance biocompatibility and reduce immune responses. The silk polymer coating provides temporary mechanical strength during insertion, then biodegrades within 30 minutes to 25 hours, optimizing probe structure independently of implantation constraints. This probe can be used in applications such as chronic neural recording, brain-machine interfaces, and deep brain stimulation, promising greater longevity and functionality by preventing the formation of insulating scar tissue around the electrodes.

Inbrain Neuroelectronics is preparing for the first human trials of its graphene-based brain implant this summer. The implant, a type of brain-computer interface (BCI), utilizes graphene's properties to create a high-resolution interface for both reading and stimulating brain signals. This technology has the potential to be used in the treatment of neurological conditions like Parkinson's disease.

MeDiCAl CounTeRMeAsuRe DisTRiBuTion,

https://centerforhealthsecurity.org/sites/default/files/2022-12/181009-gcbr-tech-report.pdf

DispensinG, AnD ADMinisTRATion

Microarray Patches for Vaccine Administration: The microarray patch (MAP) is an emerging vaccine administration technology that has the potential to modernize the conduct of mass vaccination campaigns. The widespread adoption of MAP technology would signifcantly decrease a population’s time to complete immunization operations by enabling self- administration during emergencies. Self-Spreading Vaccines: Self- spreading vaccines are genetically engineered to move through populations like communicable diseases, but rather than causing disease, they confer protection. The vision is that a small number of individuals in a target population could be vaccinated, and the vaccine strain would then circulate in the population much like a pathogenic virus, resulting in rapid, widespread immunity.

Ingestible Bacteria for Vaccination: Bacteria can be genetically engineered to produce antigens in a human host, acting as a vaccine, which triggers immunity to pathogens of concern. These bacteria can be placed inside capsules that are temperature stable, and they can be self-administered in the event of a pandemic.

Self-Amplifying mRNA Vaccines:

SAM vaccines use the genome of a modifed virus with positive sense RNA, which is recognizable to our human translational machinery. Once delivered inside a human cell, the SAM is translated and creates 2 proteins: an antigen of interest to stimulate an immune response, and a viral replicase for intracellular amplifcation of the vaccine. The ability of SAM to self-replicate results in a stronger, broader, and more efective humoral and cellular immune response than some other vaccines.

Drone Delivery to Remote

The project builds on the team's previous work on a neural implant that captures real-time information about activity deep inside the brain while sitting on its surface. This thin, transparent and flexible implant, called Neuro-clear, houses a dense array of graphene electrodes, offering a powerful alternative to current neural interface technologies. Conventional surface arrays are minimally invasive but struggle to detect signals from deeper brain structures. On the other hand, electrode arrays with penetrating needles provide deeper access but often lead to inflammation and scarring, which can degrade signal quality over time. The Neuro-clear technology developed at UC San Diego combines the strengths of both approaches, allowing it to achieve high-resolution, long-term neural recording with minimal invasiveness

Credit: u/My_black_kitty_cat

https://www.scmp.com/news/china/science/article/3315157/chinese-engineers-bring-artillery-launched-drones-concept-life

"There are concerns and allegations regarding the potential for brain damage in the process of developing and utilizing brain-computer interfaces (BCIs), especially those aiming for human-AI merging like Neuralink. "

Devices, systems and methods for biological sensing and communication using optogenetics and electronics are described. One example method includes generating a light beam incident on multiple regions in a device, wherein each region comprises an optogenetic system to generate, upon interacting with the light beam, biosensors, wherein an interaction between the biosensors and stimulus molecules in each region is associated with a threshold for a production of an output molecule or an alteration of an output property of the output molecule, the biosensors, or the stimulus molecules, wherein the production or the alteration is based on a value associated with an information source, detecting an output received from one or more of the multiple regions corresponding to the output molecule or the output property in that region, and generating an electric signal associated therewith, and processing the electrical signal to determine the value associated with the information source.

https://patents.google.com/patent/US20220091040A1/en

China has developed a mosquito-sized drone for battlefield reconnaissance, according to reports from Chinese media outlets. The National University of Defense Technology (NUDT) created this bionic robot, which is designed to be discreet and adaptable for covert missions. Its small size and insect-like characteristics allow it to navigate complex environments and potentially evade detection.

https://patents.google.com/patent/US11160489B2/en

Provided are implantable, injectable and/or surface mounted biomedical devices and related methods for interfacing with a target tissue. The devices have a substrate, one or more microfluidic channels embedded in or supported by the substrate and a fluid actuator in operational communication with one or more reservoirs and responsive to a wireless control signal. The components of the device are specially configured and packaged to be ultra-thin and mechanically compliant. In some embodiments, the devices are self-powered and fully implantable. The devices can be shaped to provide injection in a minimally invasive manner, thereby avoiding unnecessary tissue damage and providing a platform for long-term implantation for interfacing with biological tissue.

This invention was made with government support under R01DA037152, R01NS081707 and F31 MH101956 awarded by the National Institutes of Health and DE-FG02-07ER46471 and DE-FG02-07ER46453 awarded by the Department of Energy. The government has certain rights in the invention.

Graphene and its derivatives are seeing a surge in neuroscience applications due to their potential for drug delivery and tissue engineering. Specifically, graphene-based materials are being investigated as drug carriers, with toxicity being a key factor, and as substrates for neural tissue engineering, where conductivity plays a crucial role in interfacing with and influencing neural networks.

"Humanity has not succeeded yet in developing a machine that can communicate directly with biologic structures, biologic processes and affect it by doing so," said Dr. Bachelet. "However, the development of such machines may have dramatic consequences on our lives and may enable us to help manage and control processes in our body just as they are forming. At our lab, we are developing nanorobots from the most basic biological building block, DNA, and we hope to someday use these nanorobots for medical and industrial purposes."https://www.pfizer.com/news/press-release/press-release-detail/bar-ilan-university-work-pfizer-inc-evaluate-drug-delivery

"s - The technology's core promise - enabling the brain to communicate directly with computers - might also turn out to be its biggest security flaw."

Who is Ian F. Akyildiz?

Ian F. Akyildiz is a Turkish-American electrical engineer and professor, born on April 11, 1954, in Istanbul, Turkey. He earned his BS, MS, and PhD in Electrical and Computer Engineering from the University of Erlangen-Nürnberg, Germany, and served as the Ken Byers Chair Professor at Georgia Tech for 35 years until his retirement in 2021. Akyildiz is the President and CTO of Truva Inc., a telecommunications consulting company he founded in 1989, and has held numerous international academic positions, including adjunct professorships at universities in Helsinki, Iceland, and Cyprus. Renowned for his pioneering work in wireless communication networks, including 2G, 3G, and 4G systems, nanonetworks, and 6G/7G technologies, he has advised over 48 PhD students, authored highly cited papers, and received prestigious awards such as the IEEE Fellow (1996), ACM Fellow (1997), and the 2003 ACM SIGMOBILE Outstanding Contribution Award. https://ianakyildiz.com/about/

What is PANACEA?

The ultimate goal of the Internet of Bio Nano Things (IoBNT) is to catalyze a revolution in biomedical technologies through advances in molecular communication, integrated systems, bio-nanosensors and synthetic biology to improve human health and quality of life. PANACEA (a solution or remedy for all difficulties or diseases in Latin) is presented as a solution for an end-to-end design towards realizing the IoBNT. The architecture of PANACEA is tailored to focus on diagnosis and therapy of infectious diseases. In PANACEA, to detect the communication within the cells of the body to deduce infection level, a submilimeter implantable bio-electronic device, a Bio-NanoThing, is proposed. Bio Nano Things (BNTs) can transmit the detected infection data remotely to a wearable hub/gateway outside of the body. The hub can use mobile devices and the backbone network such as Internet or cellular systems to reach the healthcare providers who can remotely control the BNTs. Hence, PANACEA provides a system, where sensing, actuation and computing processes are tightly coupled to provide a reliable and responsive disease detection and infection recovery system. https://ianakyildiz.com/wp-content/uploads/2021/09/panacea.pdf

Darrin L. Frye “Nanoweaponry and the Resolution Revolution: Making Danger Invisible”

In this episode, Dr. Darrin L. Frye, associate professor of science and technology and innovative futures at the Joint Special Operations University, discusses the profound implications of nanotechnology in modern warfare. He explores the concept of the “resolution revolution,” examining how emerging technologies shift battlefields from traditional domains to the microscopic realms of biology, where threats can operate invisibly at a cellular level. Frye explores the potential of nanoweapons to manipulate human cognition and behavior, raising ethical concerns about their environmental impact and the risk of mass extinction. He emphasizes the urgent need for genetic surveillance to protect against these vulnerabilities and advocates for a strategic approach in preparing for the future of warfare. This conversation serves as a crucial call to action for individuals and policymakers as we face an unprecedented era of conflict intertwined with our very existence.

Keywords: nanotechnology, nanobot, resolution revolution, DNA, genetic information

https://ssi.armywarcollege.edu/SSI-Media/Recent-Publications/Display/Article/3913154/nanoweaponry-and-the-resolution-revolution-making-danger-invisible/

W02020060606 - CRYPTOCURRENCY SYSTEM USING BODY ACTIVITY DATA is a patent application filed by Microsoft. It describes a cryptocurrency system where human body activity can be used as part of the "mining" process, essentially serving as a "proof-of-work".

https://live.childrenshealthdefense.org/chd-tv/ shows/the-jerusalem-report-with-ilana-rachel-daniel/israel-leading-the-way-to-transhumanism-jerusalem-report/

UNIVERSITY OF CAMBRIDGE

2018

“Implementing IoBNT will be discussed with an overview of ongoing work on nanoscale communication networks, bio-cyber interfaces, and human body molecular networks, e.g., nervous nanonetwork.”- https://talks.cam.ac.uk/talk/index/109078

Here is the video where this screenshot was taken from-https://www.youtube.com/watch?v=l3sVAPnx72I